Home > Insider Trading > Filing (0001501134-20-000085)

Filing Details

Accession Number:: 0001501134-20-000085
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-27 17:05:45
Reporting Period:: 2020-10-05

Accepted Time:: 2020-11-27 17:05:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501134	Invitae Corp	NVTA	Services-Medical Laboratories (8071)	271701898

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1590947	F. Robert Werner	C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-10-05	30,000	$0.00	60,334	No	4	A	Direct
Common Stock	Disposition	2020-11-24	437	$46.91	60,388	No	4	S	Direct
Common Stock	Disposition	2020-11-24	1,051	$48.37	59,337	No	4	S	Direct
Common Stock	Disposition	2020-11-24	439	$49.99	58,898	No	4	S	Direct
Common Stock	Disposition	2020-11-24	400	$50.56	58,498	No	4	S	Direct
Common Stock	Disposition	2020-11-24	100	$52.12	58,398	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares issued upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3rd of the remaining award vesting on each of August 15, 2021, 2022 and 2023, subject to continued service with the Issuer through the applicable vesting dates.
Includes an aggregate of 57,610 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
The sale of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.70 to $47.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Includes 491 shares purchased under the Company's Employee Stock Purchase Plan on November 13, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.04 to $49.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.29 to $50.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.37 to $50.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.